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Although we sometimes treat it that way, a SNP that
influences risk of disease doesn’t exist in a vacuum.
Rather, it probably alters the expression of a single protein
that exists within a complex biological system, which,
in turn, is interacting with an even more complicated
environment. To fully understand disease risk, we must
consider these interactions, and this is just what the
Breast Cancer Association Consortium has started to
tackle. They pooled data from 24 studies of breast cancer
to assess combinations of well-established genetic and
environmental risk factors and determine how much
they affect the risk for breast cancer when combined.
The strongest interactions they found occurred between
a SNP in LSP1 and parity and between a SNP in CASP8
and alcohol consumption. As an example, whereas
women who have not had children have a per-allele
odds ratio for the LSP1 SNP of 1.08, this ratio increases
to 1.26 in women with at least four births. These two-
factor combinations at least give us confidence that
genetic and environmental risk factors interact to influ-
ence breast cancer risk.
Nickels et al. (2013) PLOS Genetics 9, e1003284.
Functional Screen Identifies New Genes Involved in
Walker-Warburg Syndrome
There is something to the elegance of a thoughtful genetic
screen. Brute-force sequencing might get you to a possible
causative mutation in some cases, but a screen based on
function can allow a zeroing in on specific genes on the
basis of something that is already known about the
disease process. Such is the story with Jae et al., who
knew that Walker-Warburg syndrome is caused by defects
in the glycosylation of alpha-dystroglycan, a highly modi-
fied protein that links the extracellular matrix with the
cytoskeleton. They exploited the fact that, in addition to
having this cellular function, the O-linked carbohydrate
component of alpha-dystroglycan serves as a receptor for
Lassa virus entry into host cells. They screened for haploid
cells resistant to Lassa virus entry, and voila`! The cells con-
tained mutations in genes that control alpha-dystroglycan
modification. Some of the resistant cells lacked proteins
already known to modify alpha-dystroglycan, but others
had mutations in genes that hadn’t previously been impli-
cated in this process. Putative mutations in two of these
novel genes were identified in three families affected by1Department of Human Genetics, Emory University School of Medicine, Atlan
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The AmWalker-Warburg syndrome, and—by circling back to their
screening system—the authors were able to provide func-
tional evidence that the mutations do in fact disrupt
post-translational modification of alpha-dystroglycan. I
love it when a plan comes together.
Jae et al. (2013). Sciencexpress March 21. http://dx.doi.org/
10.1126/science.1233675.
Back to Basic
Although we live in a next-gen-omics-driven world, get-
ting back to simple observational science and foundational
biochemistry can prove fruitful. Rowe et al., for example,
took an astute observation about their cell cultures and
turned it into a potential therapy for autosomal-dominant
polycystic kidney disease (ADPKD). While growing cells
that lacked Pkd1, they noted that the cell culture medium
acidified more quickly than it did with wild-type cells. Dig-
ging into this observation, they found that the medium
contained high lactate and low glucose because the
Pkd1-/- cells preferentially used aerobic glycolysis instead
of the tricarboxylic acid cycle for energy generation,
thereby mimicking the so-called Warburg effect that is a
hallmark of many tumors. Beyond the effect in cell culture,
kidneys of mice that lack Pkd1 also use high levels of
glucose and convert it to lactate, and cyst fluid from per-
sons with ADPKD contain lactate. If this altered metabolic
profile is linked to the cellular proliferation that causes
cysts in the kidney to grow, Rowe et al. wondered whether
they could shift it back to normal and interfere with dis-
ease pathogenesis. This seems to be the case: treatment
of ADPKD mice with 2DG, a glucose analog that cannot
be metabolized, inhibits glycolysis and reduces the pro-
gression of cystic kidney disease. Thus, getting back to ba-
sics—in a figurative and a literal sense—yielded a potential
treatment, 2DG, that is already used in the treatment of
some tumors.
Rowe et al. (2013). Nat. Med. 4, 488–493.
Mapping the Unmappable
More than 10 years after the completion of the human
genome, megabases of sequence remain unassigned
to a unique genomic location. Although early genetic
mapping was achieved with statistical methodologies,
much of the later genome assembly was completed with
physical mapping strategies that were based on sequence
overlap, but this approach does not work for certainta, GA 30322, USA
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stretches of the genome. Turning back to statistics,
Genovese et al. came up with a novel approach to closing
some of these sequence gaps. Their method is based on
population admixture, or the mixing of two ancestral
populations. In individuals from admixed populations,
such as African Americans, one can use marker genotyp-
ing to infer which parts of the genome came from which
ancestral population. On the basis of this idea, Genovese
et al. figured that they could use ancestry-informative
SNPs located on unmapped portions of the genome in
order to map these pieces. They genotyped the SNPs in
close to 400 African American individuals and looked
for correlation of these genotypes with inferred local
ancestry across the genome. Stacking the cards in their
favor, these correlations are expected to stretch over
longer distances than typical linkage disequilibrium
between markers. The admixture-based approach allowed
them to map about 4 Mb of euchromatic sequence, and it
also helped them uncover incorrectly mapped sequences
that turned out to be cryptic segmental duplications.
Many of these newly mapped sequences are what they
call islands of euchromatin within oceans of heterochro-
matin, and many map to the notoriously difficult-to-
unravel pericentromeric regions.
Genovese et al. (2013). Nat. Genet. 4, 406–414.642 The American Journal of Human Genetics 92, 641–642, May 2, 2Low Socioeconomic Status Associated with Risk of
Down Syndrome
The association of maternal age and risk of Down syn-
drome is incontrovertible. Although we can surmise that
this is due to the extended period that meiosis is arrested
in developing oocytes, we don’t fully understand the
biology behind the association, nor have many other risk
factors for nondisjunction been identified. Data, mostly
from model systems, hint that environmental exposures
could influence risk of nondisjunction. Now, Hunter
et al. provide intriguing evidence from the National
Down Syndrome Project that the same may be true in peo-
ple. Confirming a study by Torfs and Christianson (Birth
Defects Res. Part A Clin. Mol. Teratol. 67, 522–528), they
show that low socioeconomic status is associated with
risk of meiosis II (but not meiosis I) nondisjunction of
chromosome 21. Socioeconomic status was inferred from
factors that included the education level of the parents
and maternal grandparents, as well as household income.
Presumably, socioeconomic status is a proxy for some envi-
ronmental factor that is more directly responsible for the
risk of nondisjunction, but further work is needed to reveal
the identity of this risk factor.
Hunter et al. (2013). Genet. Med., published online April 4,
2013. http://dx.doi.org/10.1038/gim.2013.34.013
